Dr. Samantha Atkinson, PhD

Board-level executive with 16 years’ employment at the UK MHRA and, latterly, with accountability for regulatory activities across the UK supply chain, including Inspectorate (all GxPs), enforcement, licensing, clinical trials, pharmacopoeia and premarket medical devices

Expert at crisis management, dealing with national- and international-scale incident management; executive lead for the MHRA’s task force in response to the pandemic

Experience delivering reform and transformational change to highly complex national and globally significant organizations/sectors; recent examples include:

• SRO for £3.6 billion social care charging reform program
• Board member transforming pharmacy aseptic services across the NHS
• SRO for the UK’s Innovative Licensing Access Pathway (ILAP)

Internationally recognized and networked; previous co-chair of the International Coalition of Medicines Regulatory Authorities (ICMRA) COVID-19 Working Group.

Areas of Expertise:

• UK MHRA Regulatory Activities
• Business/System Transformation
• Operational and Corporate Leadership
• Emergency Response and Incident Management
• Program and Project Management